CCL5 and cancer: Evidence in the same direction was obtained in colorectal cancer, where macrophage-derived CCL5 acted through p65-STAT3 complexes that bound the COP9 signalosome promoter, giving rise to PD-L1 stabilization and up-regulation in the cancer cells.